Anixa Biosciences News

Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of cancer, today announced that treatment has commenced for the fifth patient in its ongoing Phase 1 clinical trial of its novel chimeric antigen receptor T-cell (CAR-T) therapy for ovarian cancer.

Anixa BiosciencesMay 21 12:00

Anixa Biosciences Enters JV With Cleveland Clinic for Additional Cancer Vaccines

Seeking AlphaMay 8 20:55

Anixa Biosciences Forms Cancer Vaccine Partnership With Cleveland Clinic

TipRanksMay 8 20:52

Anixa Biosciences Partners With Cleveland Clinic To Develop Cancer Vaccines

Anixa Biosciences Partners With Cleveland Clinic To Develop Cancer Vaccines

BenzingaMay 8 20:27

Anixa Biosciences Expands Partnership With Cleveland Clinic to Develop Additional Cancer Vaccines

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of...

PR NewswireMay 8 20:25

Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja

Dr. Amit Kumar interviewed in latest episode, 'The Vaccine That Could End Breast Cancer' SAN JOSE, Calif., May 6, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX

PR NewswireMay 6 20:05

Anixa Biosciences 13D Filing Shows President, COO & CFO Michael Catelani Reported A 5.25% Stake In The Co As Of April 30, 2024

Anixa Biosciences 13D Filing Shows President, COO & CFO Michael Catelani Reported A 5.25% Stake In The Co As Of April 30, 2024

BenzingaMay 4 01:34

Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of...

PR NewswireApr 30 19:45

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to Its Cancer Business Advisory Board

Anixa Chairman and CEO Dr. Amit Kumar stated, "Dr. Juneja is an accomplished medical oncologist who has earned status as a top media personality on cancer prevention and treatment innovations.

PRNewswireApr 18 20:20

Anixa Biosciences(ANIX.US) Director Buys US$49,229.52 in Common Stock

$Anixa Biosciences(ANIX.US)$ Director Titterton Lewis H jr purchased 15,009 shares of common stock on Apr 9, 2024 at an average price of $3.28 for a total value of $49,229.52.Source: Announcement What

Futu NewsApr 10 22:25

Anixa Biosciences Stockholders Affirm Confidence and Oversight

TipRanksMar 23 04:42

Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth

InvestorBrandMediaMar 22 07:20

Anixa Biosciences(ANIX.US) Director Buys US$36,300 in Common Stocks

$Anixa Biosciences(ANIX.US)$ Director Baskies Arnold M purchased 10,000 shares of Common Stocks on Mar 15, 2024 at an average price of $3.63 for a total value of $36,300.Source: Announcement What is s

Futu NewsMar 16 02:55

Anixa Biosciences(ANIX.US) Officer Buys US$96,600 in Common Stocks

$Anixa Biosciences(ANIX.US)$ Officer KUMAR AMIT purchased 30,000 shares of Common Stocks on Mar 15, 2024 at an average price of $3.22 for a total value of $96,600.Source: Announcement What is statemen

Futu NewsMar 15 23:29

Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

SAN JOSE, Calif., March 14, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of c

PR NewswireMar 14 20:45

Recap: Anixa Biosciences Q1 Earnings

Anixa Biosciences (NASDAQ:ANIX) reported its Q1 earnings results on Tuesday, March 12, 2024 at 05:00 PM.Here's what investors need to know about the announcement.EarningsAnixa Biosciences missed estim

BenzingaMar 13 05:45

Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress

PRNewswireMar 11 20:00

We Think Anixa Biosciences (NASDAQ:ANIX) Can Easily Afford To Drive Business Growth

Yahoo FinanceFeb 17 22:03

Analysts Conflicted on These Healthcare Names: Anixa Biosciences (ANIX) and InMode (INMD)

TipRanksFeb 14 01:20

Anixa Biosciences Initiates Higher Dosing in Phase 1 Study of Ovarian Cancer Treatment

Anixa Biosciences (ANIX) said Monday it started treatment of the fourth patient in its phase 1 clinical trial of its novel chimeric antigen receptor T-cell therapy for ovarian cancer. The fourth patie

MT NewswiresFeb 13 04:45